Table 4.
Summary of the molecular modeling of nine collagen peptides from SAXS and SANS
| Collagen peptide |
Rg (nm) |
M (nm) |
L (nm) |
R factors (%) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Linear model |
Best-fit MD model |
Linear model | Best-fit MD model |
Linear model | Best-fit MD model |
Linear model |
Best-fit MD model |
|||||||
| SAXS | SANS | SAXS | SANS | SAXS | SANS | SAXS | SANS | SAXS | SANS | SAXS | SANS | |||
| MBL-C | 2.19 | 2.24 | 2.31 | 2.19 | 0.98 | 1.12 | 1.10 | 9.0 | 8.9 | 7.8 | 5.0 | 11.9 | 2.8 | 11.5 |
| MBL-N | 2.22 | 2.21 | 1.73 | 2.18 | 0.97 | 1.50 | 0.98 | 8.6 | 6.8 | 8.8 | 16.9 | 10.4 | 14.3 | 9.8 |
| MBL-E | 2.37 | 2.43 | 2.43 | 2.30 | 0.99 | 1.40 | 1.40 | 10.0 | 9.2 | 8.1 | 12.0 | 12.4 | 6.5 | 12.4 |
| MBL-12 | 2.88 | 2.80 | 2.96 | 2.69 | 1.07 | 1.50 | 1.50 | 11.3 | 11.1 | 10.1 | 7.4 | 13.6 | 6.8 | 11.7 |
| (POG)10 | 2.39 | 2.33 | 2.29 | 2.36 | 1.00 | 1.20 | 1.20 | 9.3 | 8.9 | 8.3 | 4.2 | 12.3 | 3.0 | 7.4 |
| (POG)13 | 2.90 | 3.26 | 3.05 | 2.99 | 1.00 | 1.29 | 1.17 | 11.6 | 11.6 | 10.8 | 7.9 | 13.4 | 7.3 | 11.7 |
| (PPG)10 | 2.32 | n.a. | 2.39 | n.a. | 1.00 | 1.28 | n.a. | 8.8 | 9.0 | n.a. | 5.7 | n.a. | 6.1 | n.a. |
| G>A | 2.42 | n.a. | 2.48 | n.a. | 0.96 | 1.28 | n.a. | 9.3 | 9.0 | n.a. | 3.3 | n.a. | 3.0 | n.a. |
| T3-785 | 2.27 | n.a. | 2.29 | n.a. | 0.95 | 1.40 | n.a. | 8.7 | 9.0 | n.a. | 9.1 | n.a. | 5.9 | n.a. |
Analyses of the crystal-derived linear models and the best-fit MD-simulated models of nine collagen peptides (all except (POG)14). The Rg, and the M and L values were calculated from the models using SCT Rg, and GNOM P(r) analyses, respectively. The goodness-of-fit R factors were calculated by comparing the experimental scattering curves with those calculated for the linear and best-fit MD structures.
n.a. Not available.